Atlas Trials

Cyclophosphamide as Sole Graft-Versus-Host-Prophylaxis After Allogeneic Stem Cell Transplantation

Clinical trial NCT01283776 · COMPLETED

Trial details

NCT number
NCT01283776
Sponsor
University of Cologne
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple MyelomaNon-Hodgkin-LymphomaHodgkin's Disease
Start date
2011-03-01
Primary completion
2013-12-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.